Skip to content

Rigel Pharmaceuticals RIGL Single reportable segment — Other segment items

Similar metrics at other companies

Castle Biosciences logo
CSTLReportable Segment — Other segment items
$12.25M-66.9%
CareDx logo
CDNAReportable Segment — Other segment items
$13.86M+41.7%
Olaplex Holdings, Inc. logo
OLPXReportable Segment — Other segment items
$8.63M+657%
Recursion Pharmaceuticals, Inc. logo
RXRXReportable Segment — Other segment items
$13.35M-41.8%
RingCentral logo
RNGReportable Segment — Other segment items
$482.6M+2.9%
EverCommerce Inc. logo
EVCMReportable Segment — Other segment items
$8.06M+4.2%

Other financials

Income statement

See full
Revenue$58.8M+10.3%
Gross profit$54.2M+10.8%
Operating income$11.9M-7.0%
Net income$8.7M-24.4%
EPS (diluted)$0.44-30.2%

Balance sheet

See full
Cash & equivalents$24.5M-46.6%
Total debt$68.4M+5,079%
Total equity$399.9M+2,054%
Total assets$504.6M+187%

Cash flow

See full
Operating cash flow$2.7M+405%
CapEx$73.0K
Free cash flow-$22.0M

Valuation

See full
Market cap$684.39M+102%
Enterprise value$728.29M+148%
P/E1.9×-7.2×
P/S2.3×+0.6×

Profitability

See full
Gross margin93.4%+3.7pp
Operating margin41.6%+19.9pp
Net margin121.5%+103pp
FCF margin-61.7%

Returns & leverage

See full
Return on equity174.1%
Debt / equity0.2×+0.1×
Current ratio2.6×+0.4×

Where this comes from

Reported directly by Rigel Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:SegmentReportingOtherItemAmount.

The official record: Rigel Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rigel Pharmaceuticals's single reportable segment — other segment items.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Rigel Pharmaceuticals's single reportable segment — other segment items?
Rigel Pharmaceuticals (RIGL) reported single reportable segment — other segment items of $3.35M in Q1 2026.
What does single reportable segment — other segment items mean?
Encompasses miscellaneous operating costs or income items that do not fall into primary expense categories. Tracking these items helps identify non-recurring or secondary operational impacts on segment performance.